Alan J. Main

Insider Reports History

Entity
Individual
Signature
/s/ Alan J. Main, Ph.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan J. Main:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LEXICON PHARMACEUTICALS, INC. EVP, Innov & Chem Sciences Common Stock 256K $670K $2.62 Feb 28, 2024 Direct
LEXICON PHARMACEUTICALS, INC. EVP, Innov & Chem Sciences Restricted Stock Units 65.8K $172K $2.62 Feb 28, 2024 Direct
LEXICON PHARMACEUTICALS, INC. EVP, Innov & Chem Sciences Stock Option (Right to Buy) 205K Feb 8, 2024 Direct

Insider Reports Filed by Alan J. Main

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXRX LEXICON PHARMACEUTICALS, INC. Feb 28, 2024 7 -$63.9K 4 Feb 29, 2024 EVP, Innov & Chem Sciences
LXRX LEXICON PHARMACEUTICALS, INC. Feb 8, 2024 2 $0 4 Feb 12, 2024 EVP, Innov & Chem Sciences
LXRX LEXICON PHARMACEUTICALS, INC. Feb 28, 2023 7 -$45.5K 4 Mar 1, 2023 EVP, Innov & Chem Sciences
LXRX LEXICON PHARMACEUTICALS, INC. Feb 9, 2023 2 $0 4 Feb 13, 2023 EVP, Innov & Chem Sciences
LXRX LEXICON PHARMACEUTICALS, INC. Feb 28, 2022 7 -$56.3K 4 Feb 28, 2022 EVP, Innov & Chem Sciences
LXRX LEXICON PHARMACEUTICALS, INC. Feb 10, 2022 2 $0 4 Feb 14, 2022 EVP, Innov & Chem Sciences